CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
22 hedge funds and large institutions have $8.55M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
4% less capital invested
Capital invested by funds: $8.89M → $8.55M (-$340K)
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$586K | |
| 2 | +$550K | |
| 3 | +$104K | |
| 4 |
BL
BCWM LLC
Overland Park,
Kansas
|
+$63.7K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$63.3K |
Top Sellers
| 1 | -$350K | |
| 2 | -$348K | |
| 3 | -$66.2K | |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$21K |
| 5 |
RFWA
RPg Family Wealth Advisory
Burlington,
Massachusetts
|
-$16.5K |